About Bio Solution
Bio Solution is a company based in Seoul (South Korea) founded in 2000. The company has 88 employees as of December 31, 2024. Bio Solution operates in a competitive market with competitors including Incyte, LEO Pharma, Formation Bio, Arcutis and Tenaya Therapeutics, among others.
- Headquarter Seoul, South Korea
- Employees 88 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Bio Solution Co., Ltd.
-
Annual Revenue
$8.74 M (USD)3.42as on Dec 31, 2024
-
Net Profit
-$8.09 M (USD)-779.36as on Dec 31, 2024
-
EBITDA
-$2.45 M (USD)-20.8as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
88
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Bio Solution
Bio Solution is a publicly listed company on the KRX with ticker symbol 086820 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Bio Solution
Detailed funding history for Bio Solution
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bio Solution
Investment portfolio details for Bio Solution
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Bio Solution
Detailed financials for Bio Solution
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bio Solution Comparisons
Peer comparison for Bio Solution
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bio Solution
Bio Solution operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Incyte, LEO Pharma, Formation Bio, Arcutis and Tenaya Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Small molecules are developed for cancer and skin disease treatments.
|
|
| Locked | Locked | Locked |
Developer of drugs for treating dermatology diseases
|
|
| Locked | Locked | Locked |
AI-powered drug discovery platform for various diseases
|
|
| Locked | Locked | Locked |
Immunotherapeutic solutions for dermatological conditions are developed.
|
|
| Locked | Locked | Locked |
Regenerative and gene therapeutics for heart failure are developed.
|
|
| Locked | Locked | Locked |
Neurodegenerative disease therapeutics, including for Alzheimer’s and Parkinson’s, are developed.
|
Detailed competitors of Bio Solution
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bio Solution
Complete news archive for Bio Solution
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bio Solution
Bio Solution was founded in 2000.
Bio Solution is headquartered in Seoul, South Korea.
As of Dec 31, 2024, the latest employee count at Bio Solution is 88.
Annual revenue of Bio Solution is $8.74M as on Dec 31, 2024.
Biosolution is developing cell therapies using its somatic and stem cell technology platforms. The product portfolio includes KeraHeal ( a sprayable autologous keratinocyte for severe burns), KeraHeal-Allo (hydrogel based allogeneic keratinocyte therapy). Both these products are approved. Another cell therapy, CartiLife (spherical autologous chondrocytes for arthritis) in in the phase 2 trials. The company is also offering services such as human tissue models, raw materials for cosmetic treatments (skin-regenerating peptide , primary cells in vitro testing services for safety efficacy of drugs, cosmetics and their raw materials.
Bio Solution's top competitors include LEO Pharma, Formation Bio and Arcutis.
Yes, Bio Solution is publicly traded on KRX under the ticker symbol 086820.
The ticker symbol of Bio Solution is 086820 on KRX.